Feel Therapeutics

🚀 Join us at the BIO3 2024 FORUM: Empowering Greek Biotech Entrepreneurship! 🚀 We're thrilled to announce our upcoming session dedicated to driving innovation and growth within the Greek biotech sector. On the final day, we have a special segment designed to connect promising biotech startups with top-tier investors. 🌟 Connecting Biotech Startup Companies with Investors 🌟 Six visionary founders will present their groundbreaking projects to an esteemed panel of investors: 💡 Startup Founders: Dimitrios Adamos, Co-founder and CTO of Cogitat, UK Ioannis Gkouzionis, PhD, Co-founder, Aesthisis Medical, UK George Eleftheriou, Founder & CEO, Feel Therapeutics, UK Alexia Polissidis, Co-founder & CEO, Anacalypsis Therapeutics, Greece Nikos Tapinos, Founder, Tinos Therapeutics, USA Ioannis Tsamardinos, Co-founder & CSO of JADBio, Greece Investors: Stergios Anastasiadis, General Partner, Genesis Ventures, Angel Investor, Greece Aristos Doxiadis, Partner, Big Pi Ventures, Greece Iraklis Kounadis, Founder, Neweleven Capital, Greece Georgios Papadopoulos, Angel Investor, Founder of Atypon, USA Simos Simeonidis, PhD, MBA Simeonidis, Founder, CEO and CIO, Kos Biotechnology Partners, USA Andreas Stavropoulos, Partner, Threshold Venture, USA Alex Tzoukas, Managing Partner and Co-Founder, Kos Biotechnology Partners, Greece Maria Goutsou, Partner, Kos Biotechnology Partners, Greece Alexandra Tolia, VC - strategy - corporate development in Life Sciences, Greece Following this inspiring session, join us for the: 💡 Roundtable - Empowering the Hellenic Biotech Entrepreneurship 💡 Engage with industry experts as they share insights and strategies for fostering biotech innovation in Greece: Andreas Stavropoulos, Partner, Threshold Venture, USA Simos Simeonidis, PhD, MBA, Managing Partner and Co-Founder, Kos Biotechnology Partners, & Chairman of the Board & Co-Founder, Delsona Therapeutics, USA Nick Kalliagkopoulos, Partner, BigPi, Greece @Michael G. Gialouris, President & Managing Director, ASOFIN Management S.A., Greece Anta Gkelou, Partner, Sofinnova Partners, France Maria Dramalioti-Taylor, Managing Partner, Beacon Capital, UK This is an unmissable opportunity to connect, learn, and collaborate with the leading minds in biotech. Don't miss out on this interactive and empowering event! 🔗 Register now – less than one month left! 🔗 Register here 👉 https://lnkd.in/epXYfB_R Agenda 👉 https://lnkd.in/ewzwVCcY Mark your calendars and join us for this enlightening session! 📅 September 1-5, 2024 📍 Technopolis City Of Athens Co-organized with Endeavor Greece, we look forward to welcoming you to an event that promises to shape the future of Greek biotech entrepreneurship. Let's innovate together! #BIO3Forum #Biotech #Entrepreneurship #Innovation #Investors #Startups #GreekBiotech #Endeavor #bioinnovationGreece #endeavorgreece

Not your parents' mood ring! “At Feel Therapeutics, we build technology that understands people’s emotional and #mentalhealth. Our new #wearabledevice is the culmination of cutting-edge #sensortechnology, paired with #AI, to provide real-time actionable insights that will enable people to receive personalized support and care when they need it the most” emphasized Haris Tsirmpas, PhD, co-founder, and CTO of #FeelTherapeutics. #health #healthcare #healthit #mentalhealth #medicaldevice https://lnkd.in/gz873tQb

Digital Therapeutics Startups in Mental Health Landscape 1.5Q 2024 A4i Inc supports individuals with schizophrenia. AeBeZe Labs focuses on personalized DTx.  aNUma develops immersive VR experiences for mental wellness.  Arcade Therapeutics specializes in video games. AugMend Health uses AR.  BeMe Health offers services for teens.  BFB Labs focuses on biofeedback-based solutions.  Big Health is known for Daylight.  BioBeats (a Huma company) uses AI to monitor. CareLoop Health uses AI to predict, prevent, and manage schizophrenia.  DeepWell DTx focuses on games. Ellipsis Health develops voice-based technology to assess and monitor mental health conditions. Feel Therapeutics uses AI and biosensors for monitoring and predicting emotional states. Flow Neuroscience develops non-invasive brain stimulation devices paired with behavioral therapy to treat depression. Freespira offers a solution for panic attacks and PTSD. Headspace is renowned for its meditation and mindfulness app. HelloBetter offers digital therapeutic programs to treat various mental health conditions, including depression, anxiety, and stress. Koa Health combines cutting-edge technology and scientific research. Limbix Health (Big Health) focuses on adolescent mental health. Mindable Health specializes in anxiety disorders. MindCo Health offers VR-based digital therapeutics. MindDoc offers a comprehensive platform for depression, anxiety, and eating disorders. Mindset Health develops app-based digital therapeutics. Anxiety Canada is an app that provides CBT tools to manage anxiety. Mira Therapeutics uses digital platforms to deliver evidence-based interventions. Modern Health offers a comprehensive mental health platform for employers. Moneta Health specializes in an AI-driven platform. NightWare uses the Apple Watch to disrupt nightmares in individuals with PTSD. Novobeing combines mindfulness, exercise, and mental health. Oui Therapeutics develops DTx for preventing suicide. RealizedCare focuses on delivering VR solutions. Reulay Inc offers digital therapeutic programs through immersive and interactive technologies. SilverCloud® provides online therapeutic programs. SocialDream develops VR solutions for vulnerable populations such as the elderly, disabled, isolated, or hospitalized individuals. Sympatient offers Invirto®, the first VR-based anxiety therapy combined with app-based CBT at home. Tiatros Inc. focus on CBT and resilience training. Triumf Health uses gamified DTx to support children's mental health. Twill combines AI and clinical expertise to provide personalized care. Woebot Health provides an AI-powered chatbot that delivers CBT. XR Therapeutics develops immersive VR experiences for mental health therapy.

A revised understanding of psychiatry could have profound consequences for the millions of people with mental-health conditions that are currently poorly treated https://econ.st/3Quigl3

Having a child is undoubtedly one of the greatest joys in life. However, two years into parenthood myself, I am frequently reminded of how the arrival of a child is also an emotional rollercoaster that, for many parents, can present a challenge to their mental health. Postpartum depression (PPD) affects up to 1 in 5 women after childbirth, and while it’s a relatively established and recognised condition, it often still goes unreported. In fact, some estimates suggest that nearly 70% of women with PPD may go undiagnosed. But let’s not forget about the dads. Recent studies show that up to 1 in 10 new fathers also grapple with postpartum depression. This means that over 35 million parents worldwide face the challenge of PPD each year. It’s a struggle that can severely impact our lives, bringing feelings of sadness, sleepless nights, and a sense of guilt that’s difficult to shake. It can even impact the precious bond between parents and their newborns, affecting the child’s development. Until now, the only treatment for PPD was an IV injection that required hospitalization or traditional antidepressants that could take months (if ever) to be effective. But here's the exciting news!! The FDA has recently approved Zurzuvae (zuranolone), the first oral treatment for PPD in adults. Developed by Biogen and Sage Therapeutics, this novel, fast-acting medication can provide a rapid and sustained improvement in depressive symptoms within just 14 days, giving hope to millions of new parents worldwide. Overall, more precise treatments for different symptoms or types of depression are a potential game-changer for patients. If you’d like to learn more about how in Feel Therapeutics, we’re utilizing our digital precision medicine platform to support new mothers on their journey through parenthood with personalized, evidence-based programs, click here: https://bit.ly/45EPeF3 #precisionmedicine #mentalhealth #postpartumdepression #parenthood